000 01348 a2200373 4500
005 20250512005713.0
264 0 _c19890717
008 198907s 0 0 eng d
022 _a0885-3185
024 7 _a10.1002/mds.870040203
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMetzer, W S
245 0 0 _aHLA antigens in drug-induced parkinsonism.
_h[electronic resource]
260 _bMovement disorders : official journal of the Movement Disorder Society
_c1989
300 _a121-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aDyskinesia, Drug-Induced
_xgenetics
650 0 4 _aHLA Antigens
_xgenetics
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aParkinson Disease, Secondary
_xchemically induced
650 0 4 _aRisk Factors
650 0 4 _aSchizophrenia
_xdrug therapy
700 1 _aNewton, J E
700 1 _aSteele, R W
700 1 _aClaybrook, M
700 1 _aPaige, S R
700 1 _aMcMillan, D E
700 1 _aHays, S
773 0 _tMovement disorders : official journal of the Movement Disorder Society
_gvol. 4
_gno. 2
_gp. 121-8
856 4 0 _uhttps://doi.org/10.1002/mds.870040203
_zAvailable from publisher's website
999 _c2573434
_d2573434